Volume overload in dialysis: The elephant in the room, no one can see

American Journal of Nephrology

Volumn 38, Issue 1, 2013, Pages 75-77

  Agarwal, Rajiv ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CHOLESTEROL; PHOSPHORUS; POTASSIUM;

ALGORITHM; BLOOD PRESSURE; BODY COMPOSITION; DIALYSIS; DIET; DRY WEIGHT; END STAGE RENAL DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPERVOLEMIA; HYPOVOLEMIA; INTERDIALYTIC WEIGHT GAIN; MORTALITY; PATIENT MONITORING; PLASMA VOLUME; PRIORITY JOURNAL; REVIEW; SODIUM INTAKE; WEIGHT GAIN;

EID: 84879739212     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000353107     Document Type: Review

References (24)

1. Hecking M, Karaboyas A, Antlanger M, et al: Significance of interdialytic weight gain versus chronic volume overload: consensus opinion. Am J Nephrol 2013;38:78-90.
2. Leunissen KM, Menheere PP, Cheriex EC, van den Berg BW, Noordzij TC, Van Hooff JP: Plasma alpha-human atrial natriuretic peptide and volume status in chronic haemodialysis patients. Nephrol Dial Transplant 1989; 4: 382-386.
3. Lauster F, Gerzer R, Weil J, Fulle HJ, Schiffl H: Assessment of dry body-weight in haemodialysis patients by the biochemical marker cGMP. Nephrol Dial Transplant 1990; 5: 356-361.
4. Lauster F, Fulle HJ, Gerzer R, Schiffl H: The postdialytic plasma cyclic guanosine 3 ″:5 ″ -monophosphate level as a measure of fluid overload in chronic hemodialysis. J Am Soc Nephrol 1992; 2: 1451-1454.
5. Ishizaka Y, Yamamoto Y, Fukunaga T, Yokota N, Kida O, Kitamura K, Kangawa K, Minamino N, Matsuo H, Eto T: Plasma concentration of human brain natriuretic peptide in patients on hemodialysis. Am J Kidney Dis 1994; 24: 461-472.
6. Metry G, Hall C, Wikstrom B, Kallskog V, Hansell P, Danielson B: Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography. Acta Physiol Scand 2001; 171: 117-122.
7. Fagugli RM, Palumbo B, Ricciardi D, Pasini P, Santirosi P, Vecchi L, Pasticci F, Palumbo R: Association between brain natriuretic peptide and extracellular water in hemodialysis patients. Nephron Clin Pract 2003; 95:c60-c66.
8. Booth J, Pinney J, Davenport A: N-terminal proBNP -marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients? Clin J Am Soc Nephrol 2010; 5: 1036-1040.
9. Davenport A: Changes in N-terminal probrain natriuretic peptide correlate with fluid volume changes assessed by bioimpedance in peritoneal dialysis patients. Am J Nephrol 2012; 36: 371-376.
10. Papakrivopoulou E, Lillywhite S, Davenport A: Is N-terminal probrain-type natriuretic peptide a clinically useful biomarker of volume overload in peritoneal dialysis patients? Nephrol Dial Transplant 2012; 27: 396-401.
11. Agarwal R: B-type natriuretic peptide is not a volume marker among patients on hemodialysis. Nephrol Dial Transplant 2013, E-pub ahead of print. PMID: 23525529.
12. Reddan DN, Szczech LA, Hasselblad V, Lowrie EG, Lindsay RM, Himmelfarb J, Toto RD, Stivelman J, Winchester JF, Zillman LA, Califf RM, Owen WF Jr: Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial. J Am Soc Nephrol 2005; 16: 2162-2169.
13. Tandon T, Sinha AD, Agarwal R: Shorter delivered dialysis times associate with a higher and more difficult to treat blood pressure. Nephrol Dial Transplant 2013, E-pub ahead of print.
14. de Paula FM, Peixoto AJ, Pinto LV, Dorigo D, Patricio PJ, Santos SF: Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients. Kidney Int 2004; 66: 1232-1238.
15. Agarwal R, Alborzi P, Satyan S, Light RP: Dryweight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension 2009; 53: 500-507.
16. Agarwal R, Andersen MJ, Bishu K, Saha C: Home blood pressure monitoring improves the diagnosis of hypertension in hemodialysis patients. Kidney Int 2006; 69: 900-906.
17. Agarwal R, Brim NJ, Mahenthiran J, Andersen MJ, Saha C: Out-of-hemodialysis-unit blood pressure is a superior determinant of left ventricular hypertrophy. Hypertension 2006; 47: 62-68.
18. Alborzi P, Patel N, Agarwal R: Home blood pressures are of greater prognostic value than hemodialysis unit recordings. Clin J Am Soc Nephrol 2007; 2: 1228-1234.
19. Agarwal R: Blood pressure and mortality among hemodialysis patients. Hypertension 2010; 55: 762-768.
20. Agarwal R, Satyan S, Alborzi P, Light RP, Tegegne GG, Mazengia HS, Yigazu PM: Home blood pressure measurements for managing hypertension in hemodialysis patients. Am J Nephrol 2009; 30: 126-134.
21. da Silva GV, de Barros S, Abensur H, Ortega KC, Mion D Jr: Home blood pressure monitoring in blood pressure control among haemodialysis patients: an open randomized clinical trial. Nephrol Dial Transplant 2009; 24: 3805-3811.
22. Levin NW, Kotanko P, Eckardt KU, Kasiske BL, Chazot C, Cheung AK, Redon J, Wheeler DC, Zoccali C, London GM: Blood pressure in chronic kidney disease stage 5D -report from a Kidney Disease: Improving Global Outcomes controversies conference. Kidney Int 2010; 77: 273-284.
23. Agarwal R: Relative plasma volume monitoring for identifying volume-sensitive and -resistant hypertension. Semin Dial 2010; 23: 462-465.
24. Zoccali C, Torino C, Tripepi R, Tripepi G, D'Arrigo G, Postorino M, Gargani L, Sicari R, Picano E, Mallamaci F: Pulmonary congestion predicts cardiac events and mortality in ESRD. J Am Soc Nephrol 2013; 24: 639-646.